Vir Biotechnology
+$2.24 (+9.16%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.
About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEO
George A. Scangos
Employees
444
Headquarters
San Francisco, California
Founded
2016
VIR Key Statistics
Market cap
3.53B
Price-Earnings ratio
2.95
Dividend yield
—
Average volume
766.97K
High today
$26.74
Low today
$24.24
Open price
$24.24
Volume
871.35K
52 Week high
$58.00
52 Week low
$18.21
Analyst ratings
63%
of 8 ratings
Buy
62.5%
Hold
37.5%
Sell
0%
VIR Earnings
-$1.32
$0.43
$2.17
$3.92
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours